Single-shot Johnson & Johnson vaccine 'highly effective' in preventing severe COVID-19

Single-shot Johnson & Johnson vaccine 'highly effective' in preventing severe COVID-19

SBS

Published

In large clinical trials, the Johnson & Johnson vaccine's efficacy against severe disease was 85.9 per cent in the United States, 81.7 per cent in South Africa, and 87.6 per cent in Brazil.

Full Article